MedPath

PHL-GEMFIBROZIL

PHL-GEMFIBROZIL

Discontinued
DIN Number

02254859

Drug Class

Human

Market Date

Aug 4, 2004

Company
HC

pharmel inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02254859
AIG Number0116135001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AB04 GEMFIBROZIL
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:06.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

GEMFIBROZILActive
Strength: 300 MG
Monograph: GEMFIBROZIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.